Aardvark Therapeutics, Inc.
AARD
$6.41
-$0.16-2.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.14% | -131.88% | -100.46% | -290.15% | -163.66% |
| Total Depreciation and Amortization | 0.00% | 120.00% | 25.00% | 25.00% | 650.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,488.98% | 624.45% | 533.62% | 273.02% | 101.59% |
| Change in Net Operating Assets | -219.52% | 130.67% | -182.58% | -940.63% | 273.83% |
| Cash from Operations | -78.78% | -65.69% | -117.55% | -307.84% | -133.55% |
| Capital Expenditure | -- | -- | 100.00% | 20.00% | 2.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 202.63% | 130.41% | 304.41% | -- | -- |
| Cash from Investing | 205.56% | 130.41% | 304.30% | 585,020.00% | 10,217.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,266.67% | -100.00% | 68.10% | 1.18% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | 96.26% |
| Cash from Financing | 469.01% | -100.00% | 127.02% | 167.19% | -100.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,355.53% | 143.79% | 137.63% | 441.04% | -100.64% |